Literature DB >> 10716764

Lipomatosis, proximal myopathy, and the mitochondrial 8344 mutation. A lipid storage myopathy?

A Muñoz-Málaga1, J Bautista, J A Salazar, I Aguilera, R Garcia, I Chinchon, M D Segura, Y Campos, J Arenas.   

Abstract

Multiple symmetric lipomatosis (MSL) has been related in some cases to the 8344 point mutation of the tRNA-lysine gene of the mitochondrial DNA, mainly in the context of families with classic myoclonic epilepsy with ragged-red fibers (MERRF) and exceptionally in patients with proximal myopathy as the only manifestation of mitochondrial disease. We report on two families harboring the 8344 mutation. The patients presented with MSL and myopathy, expressed as limb girdle weakness in index cases and as exercise intolerance in the others. All muscle biopsies performed showed lipid storage apart from RRF and respiratory chain complexes deficiency. A possible explanation for both adipose proliferation and lipid storage myopathy in these cases is a disturbance in intermediary lipid metabolism secondary to mitochondrial respiratory chain deficiency that could be related via carnitine deficiency. Copyright 2000 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10716764     DOI: 10.1002/(sici)1097-4598(200004)23:4<538::aid-mus12>3.0.co;2-t

Source DB:  PubMed          Journal:  Muscle Nerve        ISSN: 0148-639X            Impact factor:   3.217


  8 in total

Review 1.  Genomics and genetics in the biology of adaptation to exercise.

Authors:  Claude Bouchard; Tuomo Rankinen; James A Timmons
Journal:  Compr Physiol       Date:  2011-07       Impact factor: 9.090

2.  Cbl Proto-Oncogene B (CBLB) c.197A>T Mutation Induces Mild Metabolic Dysfunction in Partial Type I Multiple Symmetric Lipomatosis (MSL).

Authors:  Ke Chen; Xinxing Wan; Liling Zhao; Shaoli Zhao; Lin Peng; Wenjun Yang; Jingjing Yuan; Liyong Zhu; Zhaohui Mo
Journal:  Diabetes Metab Syndr Obes       Date:  2020-10-06       Impact factor: 3.168

3.  Expanded phenotypic spectrum of the m.8344A>G "MERRF" mutation: data from the German mitoNET registry.

Authors:  Judith Altmann; Boriana Büchner; Aleksandra Nadaj-Pakleza; Jochen Schäfer; Sandra Jackson; Diana Lehmann; Marcus Deschauer; Robert Kopajtich; Ronald Lautenschläger; Klaus A Kuhn; Kathrin Karle; Ludger Schöls; Jörg B Schulz; Joachim Weis; Holger Prokisch; Cornelia Kornblum; Kristl G Claeys; Thomas Klopstock
Journal:  J Neurol       Date:  2016-03-19       Impact factor: 4.849

4.  Alteration of mitochondrial oxidative capacity during porcine preadipocyte differentiation and in response to leptin.

Authors:  Gui-Fen Luo; Tai-Yong Yu; Xu-Hui Wen; Ying Li; Gong-She Yang
Journal:  Mol Cell Biochem       Date:  2007-10-02       Impact factor: 3.396

5.  Mitochondrial DNA mutation load in a family with the m.8344A>G point mutation and lipomas: a case study.

Authors:  Tina Dysgaard Jeppesen; Noor Al-Hashimi; Morten Duno; Flemming Wibrand; Grete Andersen; John Vissing
Journal:  Clin Case Rep       Date:  2017-11-02

6.  MRP5 and MRP9 play a concerted role in male reproduction and mitochondrial function.

Authors:  Ian G Chambers; Praveen Kumar; Jens Lichtenberg; Pengcheng Wang; Jianshi Yu; John D Phillips; Maureen A Kane; David Bodine; Iqbal Hamza
Journal:  Proc Natl Acad Sci U S A       Date:  2022-02-08       Impact factor: 12.779

7.  An Unusual Case of Madelung's Disease with Multiple Atypical Fractures.

Authors:  Abdurrahman Tufan; Ridvan Mercan; Arif Kaya; Mehmet Engin Tezcan; Berivan Bitik; Mehmet Akif Ozturk; Seminur Haznedaroğlu; Berna Goker
Journal:  Case Rep Orthop       Date:  2012-12-31

8.  Mitochondrial DNA sequence characteristics modulate the size of the genetic bottleneck.

Authors:  Ian J Wilson; Phillipa J Carling; Charlotte L Alston; Vasileios I Floros; Angela Pyle; Gavin Hudson; Suzanne C E H Sallevelt; Costanza Lamperti; Valerio Carelli; Laurence A Bindoff; David C Samuels; Passorn Wonnapinij; Massimo Zeviani; Robert W Taylor; Hubert J M Smeets; Rita Horvath; Patrick F Chinnery
Journal:  Hum Mol Genet       Date:  2016-01-05       Impact factor: 6.150

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.